10 web-developer-university-of-liverpool Fellowship positions at Queen's University Belfast in United Kingdom
Sort by
Refine Your Search
-
To be an active member of the research team assisting in the development and pre-clinical and industrial translation of novel drug delivery systems. To assist in the planning and delivery
-
. What we offer: Beyond a competitive salary, the University offers an attractive benefits package including a holiday entitlement of up to 8.4 weeks a year, pension schemes and development opportunities
-
Research Hub. Funded by the Higher Education Authority of Ireland, SLSS is an ambitious programme of activity. It brings together two academic institutions (University of Limerick and Queen’s University
-
University offers an attractive benefits package including a holiday entitlement of up to 8.4 weeks a year, pension schemes and development opportunities. We support staff wellbeing with flexible working
-
Research Hub. Funded by the Higher Education Authority of Ireland, SLSS is an ambitious programme of activity. It brings together two academic institutions (University of Limerick and Queen’s University
-
availability of funding. What we offer: Beyond a competitive salary, the University offers an attractive benefits package including a holiday entitlement of up to 8.4 weeks a year, pension schemes and
-
attack surfaces introduced by approximation, and developing a performance-security trade-off framework to guide secure AIoT deployment. About the person: The successful candidate will have, or be close to
-
University offers an attractive benefits package including a holiday entitlement of up to 8.4 weeks a year, pension schemes and development opportunities. We support staff wellbeing with flexible working
-
competitive salary, the University offers an attractive benefits package including a holiday entitlement of up to 8.4 weeks a year, pension schemes and development opportunities. We support staff wellbeing with
-
To be an active member of the Biofunctional Nanomaterials group, led by Dr Garry Laverty, supporting the development of an enzyme-responsive peptide-like hydrogel for the sustained injectable